Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.65 USD | +1.06% | -1.16% | -9.36% |
Apr. 02 | Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer | CI |
Apr. 02 | Voyager Therapeutics, Inc. Announces CFO Changes | CI |
Financials (USD)
Sales 2024 * | 38.84M | Sales 2025 * | 51.19M | Capitalization | 411M |
---|---|---|---|---|---|
Net income 2024 * | -98M | Net income 2025 * | -106M | EV / Sales 2024 * | 2.44 x |
Net cash position 2024 * | 316M | Net cash position 2025 * | 373M | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
-4.21
x | P/E ratio 2025 * |
-4.31
x | Employees | 162 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.71% |
Latest transcript on Voyager Therapeutics, Inc.
1 day | +1.06% | ||
1 week | -4.14% | ||
Current month | -17.83% | ||
1 month | -17.39% | ||
3 months | +1.06% | ||
6 months | +12.33% | ||
Current year | -9.36% |
Managers | Title | Age | Since |
---|---|---|---|
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 22-02-28 |
Michael Higgins
CHM | Chairman | 61 | 15-07-21 |
Director of Finance/CFO | 55 | 22-09-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Scangos
BRD | Director/Board Member | 76 | 23-05-08 |
James Geraghty
BRD | Director/Board Member | 70 | 13-12-31 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 17-01-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 7.57 | +0.93% | 324,119 |
24-04-19 | 7.5 | -0.66% | 516,459 |
24-04-18 | 7.55 | -2.45% | 1,015,265 |
24-04-17 | 7.74 | -3.01% | 785,424 |
24-04-16 | 7.98 | -3.16% | 398,336 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.36% | 411M | |
+3.13% | 42.11B | |
+48.83% | 40.08B | |
+8.49% | 40B | |
-10.82% | 26.87B | |
+8.26% | 24.58B | |
-23.69% | 18.44B | |
+1.58% | 11.94B | |
+32.83% | 11.66B | |
+6.63% | 11.01B |
- Stock Market
- Equities
- VYGR Stock